The management of low-stage non-seminomatous germ cell tumors | Zendy

Louise Lim | Zendy; Thomas Powles | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The management of low-stage non-seminomatous germ cell tumors

Author(s) -

Louise Lim,

Thomas Powles

Publication year - 2012

Publication title -

oncology reviews

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.637

H-Index - 21

eISSN - 1970-5565

pISSN - 1970-5557

DOI - 10.4081/oncol.2012.207

Subject(s) - medicine , stage (stratigraphy) , germ cell tumors , germ cell , retroperitoneal lymph node dissection , dissection (medical) , chemotherapy , adjuvant , adjuvant chemotherapy , disease , oncology , surgery , cancer , testicular cancer , gene , paleontology , biochemistry , chemistry , breast cancer , biology

The prognosis of patients with stage I non-seminomatous germ cell tumors is in general very good. However, a large number of patients relapse with metastatic disease after orchidectomy Therefore, adjuvant treatment, in the form of either chemotherapy or retroperitoneal dissection is recommended, although active surveillance has been found to be as good a way of treating these patients with overall excellent results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research